investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Development of covalent PIP4K2 inhibitors for the treatment of p53 deficient lung tumors

Nathanael Schiander Gray

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

No posts

Related projects

A. Mcgarry Houghton

Neutrophil Elastase Links Idiopathic Pulmonary Fibrosis and Lung Cancer

Trachea, bronchus and lung

Christopher S Garris

The Role of Driver Mutations in Lung Cancer Response to Anti-PD-1 Therapy

Trachea, bronchus and lung

Gregory J Hannon

Cold Spring Harbor Laboratory Cancer Research Center

Trachea, bronchus and lung

Munira Basrai

Molecular Determinants of Chromosome Transmission and Cell Cycle Regulation

Trachea, bronchus and lung

Kwok Kin Wong

Therapeutic strategies for specific subsets of KRAS mutant lung cancers

Trachea, bronchus and lung

Saikrishna Yendamuri

MicroRNA profiling to predict recurrence after resection of early lung cancer

Trachea, bronchus and lung

Elsa Flores

Drug Repositioning for Pharmacological Manipulation of p53 Family Members in p53 Mutant and Deficient Lung Tumors

Trachea, bronchus and lung

Pathology

Eusebio Manchado-Robles

Drivers and dependencies as therapeutic targets in KRAS-mutant lung cancers

Trachea, bronchus and lung

Bruce E. Johnson

EGFR Mutations in Non-Small Cell Lung Cancer

Trachea, bronchus and lung